One Gustave L. Levy Place,
Dr Thomas Oxley - 2018 Advance Life Sciences Award Winner
A neuroscientist and interventional neurologist, Dr Thomas Oxley has performed over 1300 endovascular neurosurgical procedures at Mount Sinai Hospital in New York City.
He’s also developing a technology called Stentrode, that will enable people with paralysis to communicate and control assistive technologies with their minds.
The Stentrode technology has achieved widespread international media attention including an endorsement by the former President of The United States, Barack Obama.
In 2018 Dr Oxley received the Netexplo award for Innovation from UNESCO, and the Innovator of the Year award from the Congress of Neurological Surgeons, and can now add the Advance Award for Life Sciences.
An alumni of the University of Melbourne, Dr Oxley loves the innovative atmosphere of New York City but misses meat pies and the footy.
Meet Dr Thomas Oxley - 2018 Advance Life Sciences Award Winner and Overall Winner
When it comes to Dr Thomas Oxley's work, imagine a digital spinal cord that streams your thoughts. Dr Oxley is on the global stage in the new industry of brain-computer interfaces via his company, Synchron, which is revolutionising human interaction with the digital world. Dr Oxley is a vascular and interventional neurologist and world expert in endovascular bionics. His company's mission is to deliver safe neurotechnology that overcomes human limitations and enables growth. It is developing minimally-invasive technology for the safe and rapid implantation of miniaturised electronic medical devices with a broadband capability. Its products are designed to help diagnose and treat a range of neurological disorders including speech deficit, paralysis, epilepsy, movement disorders and depression. Dr Oxley is Instructor, Attending, and Director of Innovation Strategy in the Department of Neurosurgery, Mount Sinai Hospital, New York City and Laboratory Head of the Vascular Bionics Laboratory at the University of Melbourne. He has founded three companies since 2012, privately raising a total of $7.5 million. He moved to New York in 2015.
Meet Dr Thomas Oxley - 2018 Advance Life Sciences Award Winner and Overall Winner
When it comes to Dr Thomas Oxley's work, imagine a digital spinal cord that streams your thoughts. Dr Oxley is on the global stage in the new industry of brain-computer interfaces via his company, Synchron, which is revolutionising human interaction with the digital world. Dr Oxley is a vascular and interventional neurologist and world expert in endovascular bionics. His company's mission is to deliver safe neurotechnology that overcomes human limitations and enables growth. It is developing minimally-invasive technology for the safe and rapid implantation of miniaturised electronic medical devices with a broadband capability. Its products are designed to help diagnose and treat a range of neurological disorders including speech deficit, paralysis, epilepsy, movement disorders and depression. Dr Oxley is Instructor, Attending, and Director of Innovation Strategy in the Department of Neurosurgery, Mount Sinai Hospital, New York City and Laboratory Head of the Vascular Bionics Laboratory at the University of Melbourne. He has founded three companies since 2012, privately raising a total of $7.5 million. He moved to New York in 2015.
Dr Thomas Oxley is the 2018 Advance Life Sciences Award Winner.
Dr Thomas Oxley - 2018 Advance Life Sciences Award Winner
When it comes to Dr Thomas Oxley's work, imagine a digital spinal cord that streams your thoughts. Dr Oxley is on the global stage in the new industry of brain-computer interfaces via his company, Synchron, which is revolutionising human interaction with the digital world. Dr Oxley is a vascular and interventional neurologist and world expert in endovascular bionics. His company's mission is to deliver safe neurotechnology that overcomes human limitations and enables growth. It is developing minimally-invasive technology for the safe and rapid implantation of miniaturised electronic medical devices with a broadband capability. Its products are designed to help diagnose and treat a range of neurological disorders including speech deficit, paralysis, epilepsy, movement disorders and depression. Dr Oxley is Instructor, Attending, and Director of Innovation Strategy in the Department of Neurosurgery, Mount Sinai Hospital, New York City and Laboratory Head of the Vascular Bionics Laboratory at the University of Melbourne. He has founded three companies since 2012, privately raising a total of $7.5 million. He moved to New York in 2015.
Dr Thomas Oxley is the 2018 Advance Life Sciences Award Winner and the 2018 Overall Winner.
The Advance Awards celebrate international Australians who exhibit remarkable talent, exceptional vision and ambition. The Awards are the only of their kind to recognise the contributions of the one million Australians living abroad, and those who have returned home.
advanceawards.com
The 2018 Advance Awards were presented by Advance, the preeminent global community of high achieving Australians and alumni abroad. Advance forges connections with the one million Australian diaspora, drawing on their experience and networks to open doors and opportunities for Australia, Australian companies and Australians around the globe.
advance.org